Chemoinformaics analysis of S-Petasitolide-A
| Molecular Weight | 350.48 | nRot | 3 |
| Heavy Atom Molecular Weight | 324.272 | nRig | 17 |
| Exact Molecular Weight | 350.155 | nRing | 3 |
| Solubility: LogS | -4.717 | nHRing | 1 |
| Solubility: LogP | 4.687 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 50 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 55.1746 |
| nHD | 0 | BPOL | 33.7514 |
| QED | 0.653 |
| Synth | 4.762 |
| Natural Product Likeliness | 2.182 |
| NR-PPAR-gamma | 0.926 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.014 |
| Pgp-sub | 0.097 |
| HIA | 0.016 |
| CACO-2 | -4.714 |
| MDCK | 0.0000158 |
| BBB | 0.342 |
| PPB | 0.965694 |
| VDSS | 0.789 |
| FU | 0.0613165 |
| CYP1A2-inh | 0.381 |
| CYP1A2-sub | 0.329 |
| CYP2c19-inh | 0.254 |
| CYP2c19-sub | 0.586 |
| CYP2c9-inh | 0.704 |
| CYP2c9-sub | 0.941 |
| CYP2d6-inh | 0.564 |
| CYP2d6-sub | 0.617 |
| CYP3a4-inh | 0.652 |
| CYP3a4-sub | 0.489 |
| CL | 10.581 |
| T12 | 0.277 |
| hERG | 0.002 |
| Ames | 0.041 |
| ROA | 0.149 |
| SkinSen | 0.932 |
| Carcinogencity | 0.7 |
| EI | 0.148 |
| Respiratory | 0.965 |
| NR-Aromatase | 0.888 |
| Antiviral | Yes |
| Prediction | 0.770825 |